September 2026 update on foreskin regeneration research: the implantation study is complete with no rejection, and recellularization work is scaling up.

Foregen's Q3 2026 donor call transcript: foreskin regeneration progress from the Slovakia lab, recellularization milestone 3, bioreactor work, and Q&A.

Foregen's August 2026 update: two new grants for our Slovakian research partners, a new team interview series, and where keratinocyte recellularization stands.

Sit down with Chief Operations Officer Ryan Jones and hear how Foregen actually runs: the monthly research reports, the budgets and roadmaps, the move to Slovakia, and exactly where every donated dollar goes. Ryan explains how a graduate school class led him to discover that the World Health Organi

YouTube video by Foregen

YouTube video by Foregen

A close look at the research behind infant circumcision—HIV trials, AAP doubts, and why most of the world's doctors don't recommend it. Is it really healthier?

Our leadership visited Foregen's Slovakia lab to see recellularization progress firsthand and recorded the research team answering your top questions.

Foregen's redesigned website is live, our team presented at the Intact Global Conference, and a Slovakia site visit and recellularization fundraiser are next.

Foregen is a nonprofit pioneering regenerative medicine to restore the foreskin in form, function, and sensation. Follow our progress and support the science.

This May, we're heading to Slovakia to sit down with Ján Kováč, Foregen's Chief Bioengineer, for a special recorded Q&A session. This is your chance to ask Ján anything about the science behind foresk...

Foregen's March 2026 newsletter: recellularization scales to larger samples, biomechanical testing completed in Graz, and in vivo safety studies progress toward publication.

Foregen’s 2025 Year in Review highlights major scientific and community milestones, including the launch of our new preclinical research collaboration with Dr. Stanislav Žiaran in Bratislava, a May si...

Foregen achieves successful pilot recellularization across 50 samples. Fibroblasts and stem cells verified on scaffolds via confocal microscopy.

Foregen raises $62,959 to fund bioreactor scaling, prepares to complete Milestone 3, and moves toward the final preclinical phase: Milestone 4

Foregen surpasses its $25k goal, raising $34,748 to fund bioreactor automation. Learn how this success accelerates our

YouTube video by Foregen

Foregen hits major milestones in pre-clinical research: Dr. Palumbo's rat trial results are published, and decellularization is confirmed successful on all 20 samples.

YouTube video by Foregen

Foregen supports new JME article by Max Buckler arguing major medical bodies (AAP) influence circumcision policies with cultural and non-medical biases, violating non-maleficence. Demand transparency ...

Background Penile sexual sensation relies on intricate neural structures that remain incompletely characterized. Immunohistological insights into their development and organization can enhance under...

YouTube video by Foregen

YouTube video by Foregen

Explore Foregen’s official white paper outlining the scientific, ethical, and clinical foundation for foreskin regeneration. Download the full PDF.

Explore age-related changes in human foreskin innervation and mechanosensitivity. Learn how nerve density evolves from infancy to maturity, impacting touch sensation and informing regenerative medicin...

Join Foregen's $25,000 matching campaign in July 2025 and double your impact for regenerative medicine. Every dollar donated up to July 31st will be matched, thanks to Foregen board member Shingo Lavi...

YouTube video by Johns Hopkins Medicine